Assessment of the impact of renal impairment on systemic exposure of new molecular entities: evaluation of recent new drug applications by Zhang Y, Zhang L, Abraham S, Apparaju S, Wu T-C, Strong J M, Xiao S, Atkinson A J, Thummel K E, Leeder J S, Lee C, Burckart G J, Lesko L J, Huang S-M in Clinical pharmacology and therapeutics (2009).

[PMID: 19020495] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.